Dr. Gyanendra Singh

Present Designation

Scientist ‘B’

Division Toxicology

Educational Qualification

Ph.D. (Toxicology) - CDRI, Lucknow & JNU, New Delhi
PDF (Molecular Biology) - USA

Contact Number


E-mail Address

singh.gyanendra{AT}gov{DOT}in, gyancdri{AT}gmail{DOT}com


  1. American College of Toxicology (Ex Full sponsored membership)
  2. American Society for Virology (Ex Nominated Associate membership)
  3. American Society for Microbiology (Ex Contributing membership)
  4. Indian Society for the Study of Reproduction and Fertility (Life membership)


  1. ICMR-IIT Kharagpur Med Tech Internship Award 2017
  2. Prof. ‘GP Talwar Young Scientist Award’ at ISSRF 2017, organized by ICMR, New Delhi.
  3. ABAP- 2015 ‘Young Scientist Award’ by Association of Biotechnology & Pharmacy at Guntur, A.P.
  4. Awarded fellowship to attend ‘International Training on Environmental Toxicology’ at Bangkok, Thailand
  5. Postdoctoral Researcher at LSU Health Sciences Center/Louisiana Vaccine Center & K-State, Manhattan, USA
  6. Editor: Journal of Metabolomics and Systems Biology
  7. Associate Editor: Universal Journal of Biotechnology & Bioinformatics
  8. Lead Faculty – Toxicology; Virology – Webmedcentral, U.K.
  9. Ex-Vice-President - LSU Health Sciences Center, Postdoctoral Association, New Orleans.
  10. Marquis Who's Who in America 2011 Biography selected (65th Edition).
  11. National Eligibility Test, CSIR - UGC (NET) - 2003.
  12. National Eligibility Test, ASRB - ICAR (NET) - 2004.
  13. Graduate Aptitude Test in Engineering (GATE) - 2002 with 92.39 Percentile, conducted by Indian Institute of Science, Bangalore.

Foreign Visits

USA, Thailand

Human Resource Development

PhD in Toxicology - 01 (awarded), M.Sc. dissertations - 08

Research Interest

Toxicology, Cancer biology, Infectious disease, Heavy metal toxicity


  1. Sharma S, Dewan A and Singh G* (2017). Toxico-vigilance – An inevitable prerequisite to keep a watch on toxins around you. Journal of Forensic and Legal Medicine Jan; 45:32-35.
  2. Sharma S, Kumar K and Singh G. (2017). An Overview on Narcotic Drugs and Psychotropic Substances Act, 1985. Journal of Forensic Sciences and Criminal Investigations, 4(4): 555644.
  3. Sharma S, Vasan D A and Singh G (2017). Dangers to the Environmental Health of Gujarat – A Forthcoming Industrial Hub of India. International Journal of Trend in Research and Development Feb; 4(1), ISSN: 2394-9333.
  4. Gao X, Pham TH, Feuerbacher LA, Chen K, Hays MP, Singh G, Rueter C, Guerrero RH, Hardwidge PR (2016). Citrobacter rodentium  NleB Inhibits Tumor Necrosis Factor (TNF) Receptor-Associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production. Journal of Biological Chemistry. Aug 26;291(35):18232-8.
  5. Shirish A, Kapadia V, Kumar S, Kumar S, Mishra, SD, Singh G (2016). Effectiveness of Cooling Jacket with Reference to Physiological Responses in Iron Foundry Workers. Journal of Occupational Safety and Ergonomics Dec;22(4):487-493)
  6. Singh G* and Sinha N (2016). An In-Vitro System to Assess Teratogenicity of Drugs / E Environmental Toxicants.  ISSRF Newsletter (18th edition) Feb; 31-33.
  7. Singh G*, Maurya R, Kumar A and Sinha N (2015). Role of Apoptosis in Mediating Diclofenac Induced Teratogenesis - An In Vitro Approach. Toxicology & Industrial Health 31(7) 614–623
  8. Pham TH, Gao X, Singh G, Hardwidge PR (2013). Escherichia coli virulence protein NleH1 interaction with the v-crk sarcoma virus CT10 oncogene-Like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/NF-kappaB pathway. Journal of Biological Chemistry. Nov 29;288 (48):34567-74
  9. Singh G*, Kumar A and Sinha N (2012). Studying Significance of Apoptosis in Mediating Tolbutamide Induced Teratogenesis In Vitro. Fundamental & Clinical Pharmacology Aug; 26(4): 484-94
  10. Kelly B L, Singh G, and Aiyar A  (2011). Molecular and cellular characterization of an AT - hook protein from Leishmania. PLoS One (6(6): e21412
  11. Washington A, Singh G and Aiyar A, (2010). Diametrically opposed effects of hypoxia and oxidative stress on two viral transactivators. Virology Journal May 10; 7:93
  12. Singh G, Aras S, Zea AH, Koochekpour S and Aiyar A (2009). Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains. Journal of Virology 83(9): 4227-4235.
  13. Aras S, Singh G*, Johnston K, Foster T, Aiyar A (2009). Zinc-coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1. PLoS Pathogens (5(6):e1000469).
  14. Aiyar A, Aras S, Washington A*, Singh G* and Luftig R B (2009). Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats. Virology Journal Mar 5; 6:29.
  15. Bhattacharjee PS, Neumann DM, Foster TP, Clement C, Singh G, Thompson HW, Kaufman HE, Hill JM (2008). Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Investigative Ophthalmology and Visual Science Oct: 49(10):4263-8.
  16. Shankar S, Singh G and Srivastava RK (2007).  Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.  Frontiers in Bioscience,1(12):4839-54
  17. Bhadauria S, Singh G, Sinha N and Srivastava S. (2007). Isoniazid induces oxidative stress, mitochondrial dysfunction and apoptosis in Hep G2 cells. Cellular and Molecular Biology, 53: 102-14.
  18. Singh G, Sinha N, Koushik  JC, Mathur SK and Srivastava S (2005).  Detecting role of apoptosis in mediating cyclophosphamide induced teratogenesis in vitro. Toxicology Mechanisms and Methods, 15(6):391-7.